Clinical chemistry in women treated with progestogen implants

H. B. Croxatto, S. Diaz, M. Pavez

Resultado de la investigación: Article

13 Citas (Scopus)

Resumen

Effects on metabolic parameters of six subdermal implants of d-norgestrel, norgestrienone (R2010) and methyl-norgestrienone (R2323) were studied in women. In general, tests remained within the normal range. An exception was increases in serum transaminase levels in several subjects on R2323 implants. Average cortisol values showed a tendency to decrease on all three regimens, but remained within the normal range and the decreases met tests for statistical significance only with R2323 at six months and R2010 at 12 months. Serum cholesterol levels showed significant decreases on R2010 implants.

Idioma originalEnglish
Páginas (desde-hasta)441-450
Número de páginas10
PublicaciónContraception
Volumen18
N.º4
DOI
EstadoPublished - 1978

Huella dactilar

Norgestrienone
Clinical Chemistry
Progestins
Gestrinone
Reference Values
Norgestrel
Transaminases
Serum
Hydrocortisone
Cholesterol

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynaecology
  • Reproductive Medicine

Citar esto

Croxatto, H. B. ; Diaz, S. ; Pavez, M. / Clinical chemistry in women treated with progestogen implants. En: Contraception. 1978 ; Vol. 18, N.º 4. pp. 441-450.
@article{300d4da9a8ea4f34941701efdbc032c7,
title = "Clinical chemistry in women treated with progestogen implants",
abstract = "Effects on metabolic parameters of six subdermal implants of d-norgestrel, norgestrienone (R2010) and methyl-norgestrienone (R2323) were studied in women. In general, tests remained within the normal range. An exception was increases in serum transaminase levels in several subjects on R2323 implants. Average cortisol values showed a tendency to decrease on all three regimens, but remained within the normal range and the decreases met tests for statistical significance only with R2323 at six months and R2010 at 12 months. Serum cholesterol levels showed significant decreases on R2010 implants.",
author = "Croxatto, {H. B.} and S. Diaz and M. Pavez",
year = "1978",
doi = "10.1016/0010-7824(78)90028-8",
language = "English",
volume = "18",
pages = "441--450",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "4",

}

Clinical chemistry in women treated with progestogen implants. / Croxatto, H. B.; Diaz, S.; Pavez, M.

En: Contraception, Vol. 18, N.º 4, 1978, p. 441-450.

Resultado de la investigación: Article

TY - JOUR

T1 - Clinical chemistry in women treated with progestogen implants

AU - Croxatto, H. B.

AU - Diaz, S.

AU - Pavez, M.

PY - 1978

Y1 - 1978

N2 - Effects on metabolic parameters of six subdermal implants of d-norgestrel, norgestrienone (R2010) and methyl-norgestrienone (R2323) were studied in women. In general, tests remained within the normal range. An exception was increases in serum transaminase levels in several subjects on R2323 implants. Average cortisol values showed a tendency to decrease on all three regimens, but remained within the normal range and the decreases met tests for statistical significance only with R2323 at six months and R2010 at 12 months. Serum cholesterol levels showed significant decreases on R2010 implants.

AB - Effects on metabolic parameters of six subdermal implants of d-norgestrel, norgestrienone (R2010) and methyl-norgestrienone (R2323) were studied in women. In general, tests remained within the normal range. An exception was increases in serum transaminase levels in several subjects on R2323 implants. Average cortisol values showed a tendency to decrease on all three regimens, but remained within the normal range and the decreases met tests for statistical significance only with R2323 at six months and R2010 at 12 months. Serum cholesterol levels showed significant decreases on R2010 implants.

UR - http://www.scopus.com/inward/record.url?scp=0018085175&partnerID=8YFLogxK

U2 - 10.1016/0010-7824(78)90028-8

DO - 10.1016/0010-7824(78)90028-8

M3 - Article

C2 - 720076

AN - SCOPUS:0018085175

VL - 18

SP - 441

EP - 450

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 4

ER -